Augustina Isioma Ikusemoro: Thalassaemia is Not Just Anaemia – It’s a Genetic Story That Shapes
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Thalassaemia: It’s not just anaemia – it’s a genetic story that shapes outcomes.
Behind every microcytic blood film lies a deeper question:
Is this iron deficiency… or something inherited?
Thalassaemia is a disorder of globin chain synthesis, where the body cannot produce normal amounts of alpha or beta globin chains, leading to ineffective red cell production and varying degrees of anaemia.
Here’s what truly matters clinically:
The genetics define the disease
- Alpha-globin genes are located on chromosome 16
- Beta-globin genes are located on chromosome 11
Most α-thalassaemia cases are caused by gene deletions.
This is a key distinction – especially when interpreting microcytosis with normal iron studies.
Severity depends on how many gene copies are affected:
- Loss of 1–2 genes leads to mild or asymptomatic
- Loss of 3 genes leads to moderate to severe disease
- Loss of all 4 genes leads to Hydrops fetalis (Hb Bart’s) — often fatal without intervention
This is why thalassaemia should never be approached as ‘just another anaemia.’
It requires:
- Understanding of genetic patterns
- Correlation with RBC indices and Hb analysis
- Awareness of population risk and inheritance patterns
Because accurate diagnosis is not just academic – it directly impacts:
- Patient management
- Genetic counselling
- Prenatal outcomes
The real takeaway?
- Don’t just treat anaemia.
- Understand the biology behind it.
When you understand the genes, you diagnose with precision.
— Signature of Blood Doki
Educate.
Empower.
Elevate.”

Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Sep 25, 2026, 15:00Sarah Richardson: Finding Strength Through Bleeding Disorders Advocacy
-
Sep 25, 2026, 14:54James Fildes: Modeling Device Related Thrombosis in Multi Organ Systems
-
Sep 25, 2026, 14:51Platelet Metabolic Reprogramming: How Cellular Energy Drives Thrombosis
-
Sep 25, 2026, 14:46Thomas Maxwell: From Hemophilia Shame to Strength – Walking for Bleeding Disorders
-
Sep 25, 2026, 14:35Sarita Rani Jaiswal: Sharing Basic Science Insights at EBMT HWP 2026
-
Sep 25, 2026, 14:12Managing Breakthrough Bleeds in Hemophilia – National Bleeding Disorders Foundation
-
Sep 25, 2026, 13:50Alejandro González Veliz: Beyond the Golden Hour in Stroke Care
-
Sep 25, 2026, 13:32Gevorg Yaghjyan: Low Drug Levels, Higher Cardiovascular Risk in Lupus
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?